Advanced Respiratory and Sleep Medicine, PLLC | Huntersville, NC
Status and phase
Conditions
Treatments
About
The aim of this study is to quantify the change in blood pressure when participants with narcolepsy treated with high-sodium oxybate are transitioned to XYWAV, a low-sodium oxybate. The results of this study may provide health care providers (HCPs), patients, and payers with important new information regarding BP changes related to differences in sodium content between available oxybates for the treatment of narcolepsy.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Key Inclusion Criteria:
Key Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
170 participants in 1 patient group
Loading...
Central trial contact
Clinical Trial Disclosure & Transparency
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal